Cargando…
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
Insights into antitumor T-cell responses may help the development of more efficient treatments for lung cancer. The interplay between preexisting antitumor CD4(+) T-cell responses and platinum-based chemotherapy is crucial to improve patient survival. Accumulating evidence confirms that selecting ca...
Autores principales: | Godet, Yann, Dosset, Magalie, Borg, Christophe, Adotevi, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525622/ https://www.ncbi.nlm.nih.gov/pubmed/23264913 http://dx.doi.org/10.4161/onci.21513 |
Ejemplares similares
-
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
por: Dosset, Magalie, et al.
Publicado: (2013) -
Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022) -
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
por: Galaine, Jeanne, et al.
Publicado: (2015) -
Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
por: Thomas, Lawrence J, et al.
Publicado: (2014) -
Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)